PHENY-PAS-TEBAMIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Pheny-pas-tebamin, and when can generic versions of Pheny-pas-tebamin launch?
Pheny-pas-tebamin is a drug marketed by Pharm Res Assoc and is included in one NDA.
The generic ingredient in PHENY-PAS-TEBAMIN is phenyl aminosalicylate. There are two hundred and nine drug master file entries for this compound. Additional details are available on the phenyl aminosalicylate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PHENY-PAS-TEBAMIN?
- What are the global sales for PHENY-PAS-TEBAMIN?
- What is Average Wholesale Price for PHENY-PAS-TEBAMIN?
Summary for PHENY-PAS-TEBAMIN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 73 |
| Patent Applications: | 658 |
| DailyMed Link: | PHENY-PAS-TEBAMIN at DailyMed |
US Patents and Regulatory Information for PHENY-PAS-TEBAMIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharm Res Assoc | PHENY-PAS-TEBAMIN | phenyl aminosalicylate | POWDER;ORAL | 011695-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Pharm Res Assoc | PHENY-PAS-TEBAMIN | phenyl aminosalicylate | TABLET;ORAL | 011695-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
